Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Use baby moisturizers by NeoChine
The First People's Hospital of Lianyungang
Neonatal Jaundice
1 trial -
Using medical biological glue for filling And Using the meniscus suture system
The First People's Hospital of Lianyungang
Unilateral Meniscus Tear of the Knee Joint
1 trial -
Venclexta 100 MG Oral Tablet
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Vildagliptin 50 mg bid
The First People's Hospital of Lianyungang
Parkinson's Disease
1 trial -
Vitamin C
The First People's Hospital of Lianyungang
Ageing
1 trial -
Vitamin D
The First People's Hospital of Lianyungang
Development, Child
1 trial -
Vonoprazan+amoxicillin+doxycycline+bismuth for 14 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
[68Ga]P3
The First People's Hospital of Lianyungang
Neoplasms
1 trial -
anti-CD19/BCMA-UCAR-T cells
The First People's Hospital of Lianyungang
Rheumatoid Arthritis
1 trial -
bicycle ergometry test with spiroergometry
The First People's Hospital of Lianyungang
Community-acquired Pneumonia
1 trial -
circulate free methylated EBV DNA
The First People's Hospital of Lianyungang
Extranodal Natural Killer/T-cell Lymphoma
1 trial -
dexmedetomidine
The First People's Hospital of Lianyungang
Children
1 trial -
dopamine
The First People's Hospital of Lianyungang
Renal Artery Stenosis Atherosclerotic
1 trial -
drug
The First People's Hospital of Lianyungang
Hypertension
1 trial -
esketamine group
The First People's Hospital of Lianyungang
Postherpetic Neuralgia
1 trial -
fecal microbiota transplantation
The First People's Hospital of Lianyungang
Fecal Microbiota Transplantation
1 trial -
foundational treatment
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
high caloric oral nutritional supplements
The First People's Hospital of Lianyungang
Malnutrition, Child
1 trial -
high-energy digestible food E2
The First People's Hospital of Lianyungang
Caesarean Section
1 trial -
human cord blood-derived mononuclear cells (HCB-MNCs)
The First People's Hospital of Lianyungang
Refractory Diabetic Foot
1 trial -
insulin injection 15 minutes before meals
The First People's Hospital of Lianyungang
Diabetes
1 trial -
intraileal infusion
The First People's Hospital of Lianyungang
Incretins
1 trial -
intravenous immunoglobulin
The First People's Hospital of Lianyungang
Guillain-Barre Syndrome
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources